Literature DB >> 35780262

Follow-up after bariatric surgery: is it time to tailor it? Analysis of early predictive factors of 3-year weight loss predictors of unsuccess in bariatric patients.

Costantino Voglino1, Simona Badalucco2, Andrea Tirone1, Cristina Ciuoli3, Silvia Cantara4, Nicoletta Benenati3, Annalisa Bufano3, Caterina Formichi3, Federica Croce5, Ilaria Gaggelli1, Maria Laura Vuolo1, Giuseppe Vuolo1.   

Abstract

Bariatric surgery (BS) is the most effective treatment strategy for obesity. Nevertheless, a subset of patients does not reach a successful weight loss or experience long-term weight regain. Conflicting evidence exists regarding predictors of BS outcomes. We aimed to define the early factors linked to 3 year unsuccessful weight loss in order to promote a tailored close follow-up. We enrolled 443 patients who underwent BS from January 2014 to December 2018 with a 3 year follow-up. An unsuccessful BS outcome was defined as a percentage of total weight loss (%TWL) < 20. We compared the characteristics between successful and unsuccessful patients in order to identify predictor factors of unsuccess after surgery. We found that the proportion of patients with unsuccessful weight loss progressively increased from one to three years after BS. In a multiple regression model, only 1 month %TWL and sleeve gastrectomy (SG) were significantly associated with 3 year unsuccessful weight loss. We stratified our cohort in four groups according to the risk of BS unsuccess, in terms of 1 month %TWL and type of surgery (SG vs gastric bypass). Interestingly, groups showed a significant difference in terms of %TWL at each follow-up point. Patients submitted to SG with lower 1 month %TWL must be considered at higher risk of future weight regain; consequently, they require a tailored and closer follow-up.
© 2022. The Author(s).

Entities:  

Keywords:  Bariatric surgery; Follow-up; Predictors; Sleeve gastrectomy; Weight loss

Mesh:

Year:  2022        PMID: 35780262      PMCID: PMC9338161          DOI: 10.1007/s13304-022-01314-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


Introduction

The worldwide obesity rate continues to grow and it is a significant issue for individuals and the healthcare system. According to the WHO data, obesity affects about 13% of the world’s adult population and its prevalence has nearly tripled since 1975 [1]. Bariatric surgery (BS) is the most effective treatment strategy that results in significant and sustained long-term weight loss and amelioration/remission of obesity-related comorbidities [2-4]. Despite marked weight loss following BS, there is a subset of patients that fails to achieve a successful weight loss or experiences long-term weight regain. In fact, in our 3 year follow-up previous paper we reported the highest value of %Excess Weight Loss (%EWL) at 12 months after surgery and, after this time, a slight but constant decrease of %EWL with the lowest value observed at 3 years [5]. The definition of BS success/unsuccess is variably reported in literature. % EWL is one of the commonly used measures of BS outcome. In particular, the EWL > 50% was extensively reported as a criterion for BS success. However, we have decided to use % Total Weight Loss (%TWL) as anthropometric outcome measure of choice because it was, in contrast to % EWL, independent or anyway less influenced by pre-operative BMI. According to literature BS success was defined as TWL > 20% [6]. Social and demographic features, surgical procedures, mental and eating disorders, and pre-operative anthropometric variables are usually reported as weight loss predictor factors [7-9]. Despite numerous studies in this area, few robust predictors of BS unsuccess have been clearly established. Defining the early factors linked to BS unsuccess is mandatory to promote prompt intervention in order to optimize weight loss. The primary aim of this study was to identify clinical, demographic, and/or anthropometric variables associated with poor %TWL during a 3 year follow-up period.

Materials and methods

Study population

We performed a retrospective analysis of 443 patients who underwent BS for morbid obesity in the Unit of Bariatric Surgery of Siena from January 2014 to December 2018. Inclusion criteria for BS are as follows: 1 body mass index (BMI) > 40 kg/m2 or > 35 kg/m2 with co-morbidities, 2 patients ranging from 18 to 65 years old. We discussed all of the cases in a multidisciplinary team which includes a surgeon, an endocrinologist, a bariatric dietitian, and a psychiatrist specialized in obesity and eating disorders in order to decide whether to perform BS and the type of surgical procedure. Patients with incomplete follow-up or missing data were excluded from the present study. This research was approved by Ethics Committee of our Hospital. Informed consent was obtained from all patients. We recorded academic and socio-demographic factors and anthropometric data of each patient. Their medical history and previous obesity-related comorbidities, included eating and mental disorders, were also evaluated.

Surgical technique

All surgical procedures were performed with a minimally invasive approach by trained surgeons with advanced and comparable skills in bariatric surgery in order to avoid some relevant bias related to the experience of the operating team.

Sleeve gastrectomy (SG)

The procedure started with a dissection of the gastrocolic ligament. The greater curve was skeletonized from 5 cm to pylorus up to the angle of His. A complete mobilization of the gastric fundus was achieved. The left lateral portion of the stomach was resected using a 60-mm linear stapler along a bougie (36–38 Fr). At the end of the procedure, resected stomach was removed through left trocar site.

One anastomosis gastric bypass (OAGB)

Using a 60 mm linear stapler, a long and narrow gastric pouch was created. A 38-Fr bougie was used as a guide for calibration. Finally, an antecolic Billroth II-type loop gastroenterostomy was done at the small bowel 200 cm distal to the Treitz ligament.

Roux-en-Y gastric bypass (RYGB)

We began the operation by creating a stomach pouch of approximately 30 ml along a 38-Fr calibration bougie. The Roux reconstruction was performed with double loop technique. The biliopancreatic limb was set to 80 cm distal to the Treitz ligament, while the alimentary limb length was set to 150 cm. For gastrojejunostomy we carried out a side-to-side anastomosis using a mechanical stapler. A side-to-side jejunojejunostomy was performed between alimentary and biliary limbs. Finally, the biliary loop and alimentary loop were separated using a linear stapler.

Follow-up

After discharge, a personalized diet and post-operative follow-up schedule have been provided to all patients. Patients were followed up in our outpatients department by a multidisciplinary team. Medical visits were scheduled at 1, 3, 6, and 12 months in the first year, then every 6 months for the following year, and then every 12 months.

Statistical analysis

Variables not normally distributed are expressed as median and interquartile range (IQR, i.e., the range between 25 and 75th percentile) and were compared by means of non-parametric test (Mann–Whitney). The χ2 test or Fisher exact test was used to compare categorical variables. A multinomial logistic regression model was performed in order to identify the variables associated with unsuccessful BS. The Hosmer–Lemeshow test was used to evaluate the goodness-of-fit of the multivariate models. Statistical significance was determined at P value of < 0.05. For statistical analysis, SPSS statistical package (version 20.0) (SPSS™, Chicago, Illinois, USA) was used.

Results

Four hundred forty-three patients were included in our study, of which 342 (77.2%) were female. Two hundred forty-one patients (54.4%), 123 (27.7%), and 79 (17.8%) underwent sleeve gastrectomy, RYGB, and OAGB, respectively. Baseline patients’ characteristics are summarized in (Table 1). The median age of patients was 44 years old and the median pre-operative BMI was 45.5 (IQR 41.6–51). A history of eating disorders and mental disorders was present in 50.8 and 31.8%, respectively. A surprising 41.3% of our cohort was unemployed, homemakers, or retired. The majority of patients (90.3%) had almost one obesity-related comorbidity. Steatosis had been diagnosed in 61.2% of patients. Hypertension was reported in 42.4% of our sample. The 3 year remission rate of Type 2 Diabetes was reported in 86.3, 88, and 89.3% in SG, OAGB, and RYGB, respectively (p > 0.05). Sleeve gastrectomy achieved a lower dyslipidemia remission rate than OAGB and RYGB at 3 year (46.4, 70.6, and 74.4% in SG, OAGB, and RYGB group, respectively; p < 0.05). After 3 years, 47.7% of SG, 50% of OAGB, and 50.8% of RYGB had experienced arterial hypertension remission (p > 0.05).
Table 1

Baseline characteristics of 443 patients

ParameterTotal
Patients443
Sex (male; female)101; 342 (22.8%; 77.2%)
Type of surgery
Sleeve gastrectomy241 (54.4%)
OAGB79 (17.8%)
RYGB123 (27.7%)
Age (median, IQR)44 (36;52)
Place of birth
South Italy111 (25.1%)
Central Italy260 (58.7%)
North Italy14 (3.2%)
Insular Italy33 (7.4%)
Foreign country25 (5.6%)
Place of current residence
South Italy39 (8.8%)
Central Italy396 (89.4%)
North Italy8 (1.8%)
Marital status
Married or living with a partner289 (65.2%)
Divorced, widowed or single154 (34.8%)
Job
Employee260 (58.7%)
Unemployed, housewives, retired183 (41.3%)
Educational qualifications
Highschool or higher200 (45.1%)
Secondary school or lower243 (54.9%)
Dyslipidemia (yes; no)224; 219 (50.6%; 49.4%)
Arterial Hypertension (yes; no)188; 255 (42.4%; 57.6%)
Steatosis (yes; no)271; 172 (61.2%; 38.8%)
Sleep apnea (yes; no)128; 315 (28.9%; 71.1%)
Type 2 diabetes (yes; no)141; 302 (31.8%; 68.2%)
Total comorbidities (0–5)
043 (9.7%)
1101 (22.8%)
2132 (29.8%)
395 (21.4%)
458 (13.1%)
514 (3.16%)
Mental disorders (yes; no)141; 302 (31.8%; 68.2%)
Eating disorders (yes; no)225; 218 (50.8%; 49.2%)
Pre-operative BMI (median; IQR)45.5 (41.6–51)
One month %TWL11.1 (9–13.2)
Baseline characteristics of 443 patients As expected, the proportion of patients with unsuccessful weight loss progressively increased from one to three years, being 7.42, 13, and 17.16% at 12, 24, and 36 months after BS, respectively (Fig. 1). According to the 3 year %TWL, patients were divided into two groups: unsuccessful patients (%TWL < 20) and successful patients (%TWL > 20) (Table 2). Older age, rate of steatosis and sleep apnea, higher pre-operative BMI, type of surgery, place of birth, and number of total comorbidities were associated with unsuccessful BS. We also found a linear significant correlation between 1 month %TWL and 3 year %TWL (p < 0.01) (Fig. 2). The linear regression was estimated by the formula: y = 0.08x + 8, 88.
Fig. 1

Proportion of unsuccessful bariatric patients from one to three-year follow-up course

Table 2

Analysis of social, demographic and clinical parameters in unsuccessful patients (%TWL < 20), and successful patients (%TWL > 20) at 3 year follow-up

Parameter3 year %TWL < 203 year %TWL > 20p value
Patients76 (17.2%)367 (82.8%)
Sex (male; female)17; 59 (16.8%; 17.3%)84; 283 (83.2%; 82.7%)0.528
Type of surgery < 0.01
Sleeve gastrectomy62 (25.7%)179 (74.3%)
OAGB4 (5.1%)75 (94.9%)
RYGB10 (8.1%)113 (91.9%)
Age (median, IQR)49 (43–55)43 (36–50) < 0.001
Place of birth0.018
South Italy13 (11.7%)98 (88.3%)
Central Italy45 (17.3%)215 (82.7%)
North Italy2 (14.3%)12 (85.7%)
Insular Italy10 (30.3%)23 (69.7%)
Foreign country6 (24%)19 (76%)
Place of current residence0.091
South Italy4 (10.3%)35 (89.7%)
Central Italy72 (18.2%)324 (81.8%)
North Italy08 (2.2%)
Marital status0.308
Married or living with a partner52 (18%)130 (84.4%)
Divorced, widowed or single24 (15.6%)237 (82%)
Job0.230
Employee48 (18.5%)212 (81.5%)
Unemployed, housewives, retired28 (15.3%)155 (84.7%)
Educational qualifications0,381
Highschool or higher36 (18%)164 (82%)
Secondary school or lower40 (16.5%)203 (83.5%)
Dyslipidemia (yes;no)41; 35 (18.3%; 16%)183; 184 (81.7%; 84%)0.301
Arterial Hypertension (yes;no)35; 41 (18.6%; 16.1%)153; 214 (81.4%; 83.9%)0.282
Steatosis (yes;no)59; 17 (21.8%; 9.9%)212; 155 (78.2%; 90.1%)0.001
Sleep apnea (yes;no)31; 45 (24.2%; 14.3%)97; 270 (75.8%; 85.7%)0.01
Type 2 diabetes (yes;no)30; 46 (21.3%; 15.2%)111; 256 (78.7%; 84.8%)0.077
Total comorbidities (0–5)0.001
04 (9.3%)39 (90.7%)
111 (10.9%)90 (89.1%)
224 (18.2%)108 (81.8%)
316 (16.8%)79 (83.2%)
416 (27.6%)42 (72.4%)
55 (35.7%)9 (64.3%)
Mental disorders (yes;no)29; 47 (20.65%; 15.6%)112; 255 (79.4%; 84.4%)0.122
Eating disorders (yes;no)39; 37 (17.3%; 17%)186; 181 (82.7%; 83%)0.510
Pre-operative BMI (median;IQR)44.2 (40.4–48.1)46.1 (41.9–51.7)0.011
One month %TWL (median;IQR)10.4 (8.2–11.9)11.2 (9.2–13.5)0.013
Fig. 2

Linear correlation between one-month %TWL and three-year %TWL (p < 0.01)

Proportion of unsuccessful bariatric patients from one to three-year follow-up course Analysis of social, demographic and clinical parameters in unsuccessful patients (%TWL < 20), and successful patients (%TWL > 20) at 3 year follow-up Linear correlation between one-month %TWL and three-year %TWL (p < 0.01) We performed a multivariate analysis, including the variables that resulted significant from the bivariate analysis. In a multiple regression model only sleeve gastrectomy and lower %TWL at 1  month remained significantly associated with 3 year unsuccessful weight loss (Table 3). On the basis of these parameters, we stratified patients according to the risk of BS unsuccess. For calculating the cut-off of 1 month %TWL that predicts 3 year BS success, we assigned the value of 20 to the variable x in the above-mentioned formula. We obtained y = 10.48. We divided our cohort in four groups: group A (patients underwent SG with 1 month %TWL < 10.48); group B (patients underwent SG with one-month %TWL > 10.48); group C (patients underwent RYGB/OAGB with 1 month %TWL < 10.48); and group D (patients underwent RYGB/OAGB with 1 month %TWL > 10.48). Interestingly, groups showed significant difference in terms of %TWL at each follow-up point (Fig. 3).
Table 3

Association between sleeve gastrectomy and lower one month %TWL and 3 year unsuccessful weight loss in a multiple regression model

3 year %TWL < 20OR95 % CIp value
Type of surgery
 Sleeve gastrectomy2.621.193–5.7810.016
One month %TWL0.8890.818–0.9650.005

Goodness-of-fit by the Hosmer–Lemeshow test p = 0,151 (for %TWL < 20 at 3 years)

Fig. 3

%TWL at different follow-up point among four groups (group A: patients underwent SG with 1 month %TWL < 10.48; group B: patients underwent SG with 1 month %TWL > 10.48; group C: patients underwent RYGB/OAGB with one-month %TWL < 10.48; group D: patients underwent RYGB/OAGB with 1 month %TWL > 10.48)

Association between sleeve gastrectomy and lower one month %TWL and 3 year unsuccessful weight loss in a multiple regression model Goodness-of-fit by the Hosmer–Lemeshow test p = 0,151 (for %TWL < 20 at 3 years) %TWL at different follow-up point among four groups (group A: patients underwent SG with 1 month %TWL < 10.48; group B: patients underwent SG with 1 month %TWL > 10.48; group C: patients underwent RYGB/OAGB with one-month %TWL < 10.48; group D: patients underwent RYGB/OAGB with 1 month %TWL > 10.48)

Discussion

To date, BS is widely considered the most reliable therapeutic strategy which results in significant and sustainable weight loss, improvement of obesity-related comorbidities, and prolonged survival. However, a subset of patients after BS experiences unsuccessful weight loss or weight regain. This issue has important health consequences for both the patients (decreased quality of life and working force) and the public health system in terms of costs associated with managing remerging obesity and the related comorbidities. Early identification of patients who will undergo BS unsuccess may allow intensive post-operative behavior and lifestyle interventions and strict follow-up in order to maximize weight loss. In our research, we have found that the type of surgery and 1 month %TWL were associated with BS failure. These results suggested that patients at risk of BS unsuccess could be identified in the pre-operative as well as in the early post-operative period. Several authors have investigated the relationship between pre-operative BMI and post-operative weight loss after BS. Multiple studies showed that higher pre-operative BMI was correlated with worse weight trajectory. In a recent paper by Nickel and colleagues [10], the predictors of %EWL 12 months after BS were analyzed. They reported a negative significant correlation between pre-operative BMI and weight loss after surgery. Others show similar results [11-13]. In our report, we did not identify any association between pre-operative BMI and weight loss. This result could be justified by the different anthropometric outcome measures of choice that we decided to use. In fact, we preferred %TWL, instead of %EWL, because it is less influenced by pre-operative BMI. On the contrary, %EWL is strongly and negatively associated with baseline BMI [14, 15]. Reports in literature on difference in weight loss between males and females after BS are spare and conflicting. In line with D’Eusebio et al. and Obanda and colleagues we did not identify gender as a pre-operative predictor of outcome [16, 17]. Conversely, several authors reported male gender as a predictive factor of less favorable weight trajectory [18, 19]. The correlation between age and BS unsuccess is still a matter of debate. Multiple authors found an inverse significant association between age and weight loss [11, 20–22]. In a large nationwide study involving over 2000 patients who attended 5 year follow-up, Dreber and colleagues showed a greater weight loss in younger patients [23]. However, we failed to find any correlation between age and %TWL at 36 months after surgery in line with other authors [17, 24]. It is well known that increasing age is strongly linked to more comorbidities, limitation of physical activity, reduction of compliance to diet and lifestyle recommendations, and lower resting energy expenditure. Therefore, these variables could act as confounding factors leading to heterogeneous results in literature. In addition, we would emphasize that the goals of BS should be different according to the age. In older patients, who have lower life expectancies than younger patients, the primary aim of surgery is to mitigate the effect of comorbidities in order to provide important health benefits regardless of weight loss. Younger obese patients suffer from social stigma and discrimination, which has a negative impact on mental health, socialization, and attitude toward school and employment status outcomes [25]. Therefore, in these people the purpose is not only to achieve a significant improvement of obesity-related disease for many decades but also to reach a substantial and sustainable weight loss. The relationship between the above-mentioned mental health issue, employment status and the educational qualification, and the weight loss after BS has been extensively investigated by several authors, but the results are controversial. Dawes and colleagues, in a recent meta-analysis, have investigated the correlation between pre-operative mental health disorders and post-operative weight loss [26]. In consistent with our results, the authors did not find clear evidence that pre-operative psychopathologic condition was related to BS unsuccess. Emotional eating and other problematic eating behaviors are common among BS patients, but it is unclear how they may affect post-surgical outcomes. We failed to find any correlation between eating disorders and BS success in line with some studies [27, 28] but conversely to others [29, 30]. A published study showed that post-operative eating factors could play an important role in determining post-surgical weight loss more than pre-operative eating behavior [31]. In fact, post-operative grazing and uncontrolled eating are consistently associated with insufficient weight loss or weight regain [32]. In the light of the above, we would stress the importance of appropriate and close nutritional and psychiatric follow-up with the aim of preventing weight regain and/or insufficient weight loss and achieving a long-term body weight stability. In Italy, a North–South gradient is present with a higher prevalence of obesity in southern and insular regions in contrast with the north and center. The factors taken into account to explain this geographical trend include regional eating habits and socio-economic status [33-35]. Moreover, many studies reported the association between overweight and obese patients and educational attainment, but it still remains unclear whether a lower educational level is a contributing cause or effect of obesity [36]. On this basis, we decided to investigate the relationship between BS unsuccess and geographical origin, place of current residence, and educational qualification. In line with a recent paper, in our study a lower level of education was not a predictor of worse outcome [17]. Also geographical factors were not associated with weight loss after surgery. We found an increased number of comorbidities among patients with lower 3 year %TWL. However, the association not remained significant in a multivariate model. Our results are similar with previous studies [17, 20]. The magnitude of BS unsuccess after different bariatric procedures was variably reported in literature. A recent meta-analysis by Hu et al. reported that patients underwent SG experienced a worse outcome with regard to 3 year %EWL [37]. Furthermore, Chang and colleagues in a retrospective 5 year follow-up study of 247 patients who underwent SG or RYGB showed that SG is an independent risk factor of insufficient weight loss [38]. In our previous paper, we reported the non-inferiority of OAGB, in terms of 3 year %TWL, compared to RYGB [5]. In our series, SG was predictor of BS unsuccess in a multivariate analysis. This highlights the importance of clearly informing expectations and planning strict and close interventions. As already suggested by our previous work, early weight loss is one of the stronger predictors of outcomes in terms of weight loss [39]. The explanation for this phenomenon remains unclear and not completely understood. In our cohort all patients were discharged with the same diet program and post-operative follow-up schedule. According to our experience, in the first month after surgery, the adherence to the post-operative recommendations is high, and therefore, the impact of confounding factors is minimal. The reasons for the different early outcomes should be researched in the hormonal changes caused by surgery and genetic factors. Similar findings were shown by Obeidat et al. in a cohort of 190 patients who underwent SL [40]. A strong correlation between %EWL at 6 months and %EWL at 12 and 24 months was demonstrated by D’Eusebio and colleagues [16]. An early identification of patients who will fall below the normal curve for weight loss in the pre-operative/early post-operative period should be mandatory. Based on these premises, a promising strategy will be to tailor follow-up in order to improve outcomes. In fact, an ideal and adequate follow-up program should be individualized according to the predicted risk and timing of insufficient weight loss/weight regain. For this purpose, we proposed a stratification of bariatric patients in four groups of risk depending on the type of surgery and 1 month %TWL. An intensive follow-up program should be reserved for patients at high risk of weight regain with the aim of promoting a prompt multidisciplinary approach, including nutritional and psychiatric counseling, behavior intervention, and pharmacotherapy to maximize weight loss and minimize the costs of health system [41]. So far, we identify only one previous paper focused on BS unsuccess after three types of surgery [17]. A strength of our study was the size of the cohort with a complete 3 year follow-up. A further strength consists in our use of %TWL as a metric of choice for assessing weight loss across the bariatric population because it is the least influenced by pre-operative BMI. Furthermore, we first proposed a tailored follow-up program in patients at high risk of unsuccessful results after BS. Nevertheless, our study has some limitations: it is a retrospective study with a relative short 3 year follow-up; we have not analyzed some factors as change of feed, physical activity, and diet adherence, which may affect weight loss.

Conclusion

In conclusion patients submitted to SG with lower 1 month %TWL must be considered at higher risk of future weight regain; therefore, they require a strong multidisciplinary approach and tailored close follow-up with the aim of improving their outcomes. Longer follow-up studies would be desirable to collect stronger data. Further studies are needed to better identify the predictor factors of BS unsuccess focusing on hormonal changes and epigenetic features that could explain the huge differences regarding weight loss recorded since the first post-operative month and maintained up to three years after surgery.
  40 in total

1.  Overweight and Obesity in Southern Italy: their association with social and life-style characteristics and their effect on levels of biologic markers.

Authors:  Alberto R Osella; María Del Pilar Díaz; Rafaelle Cozzolongo; Caterina Bonfiglio; Isabella Franco; Daniela Isabel Abrescia; Antonella Bianco; Elba Silvana Giampiero; José Petruzzi; Lanzilota Elsa; Correale Mario; Anna María Mastrosimni; Leandro Giocchino
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2014

2.  Is sleeve gastrectomy a therapeutic procedure for all obese patients?

Authors:  Giuseppe Vuolo; Costantino Voglino; Andrea Tirone; Giuseppina Colasanto; Ilaria Gaggelli; Cristina Ciuoli; Francesco Ferrara; Daniele Marrelli
Journal:  Int J Surg       Date:  2016-04-22       Impact factor: 6.071

3.  Factors influencing long-term weight loss after bariatric surgery.

Authors:  William W Chang; Devon N Hawkins; Joel R Brockmeyer; Byron J Faler; Samuel W Hoppe; Balakrishna M Prasad
Journal:  Surg Obes Relat Dis       Date:  2019-01-09       Impact factor: 4.734

4.  Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery: A Meta-analysis.

Authors:  Aaron J Dawes; Melinda Maggard-Gibbons; Alicia R Maher; Marika J Booth; Isomi Miake-Lye; Jessica M Beroes; Paul G Shekelle
Journal:  JAMA       Date:  2016-01-12       Impact factor: 56.272

5.  Cardiovascular Benefits and Lipid Profile Changes 5 Years After Bariatric Surgery: A Comparative Study Between Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.

Authors:  Costantino Voglino; Andrea Tirone; Cristina Ciuoli; Nicoletta Benenati; Barbara Paolini; Federica Croce; Ilaria Gaggelli; Maria Laura Vuolo; Roberto Cuomo; Luca Grimaldi; Giuseppe Vuolo
Journal:  J Gastrointest Surg       Date:  2019-12-16       Impact factor: 3.452

6.  Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study.

Authors:  Anita P Courcoulas; Wendy C King; Steven H Belle; Paul Berk; David R Flum; Luis Garcia; William Gourash; Mary Horlick; James E Mitchell; Alfons Pomp; Walter J Pories; Jonathan Q Purnell; Ashima Singh; Konstantinos Spaniolas; Richard Thirlby; Bruce M Wolfe; Susan Z Yanovski
Journal:  JAMA Surg       Date:  2018-05-01       Impact factor: 14.766

7.  Age as a long-term prognostic factor in bariatric surgery.

Authors:  Gitana Scozzari; Roberto Passera; Rosa Benvenga; Mauro Toppino; Mario Morino
Journal:  Ann Surg       Date:  2012-11       Impact factor: 12.969

8.  Problematic Eating Behaviors Predict Outcomes After Bariatric Surgery.

Authors:  Lisa R Miller-Matero; Kelly Bryce; Caroline K Saulino; Kate E Dykhuis; Jeffrey Genaw; Arthur M Carlin
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

9.  Advantages of percent weight loss as a method of reporting weight loss after Roux-en-Y gastric bypass.

Authors:  Ida J Hatoum; Lee M Kaplan
Journal:  Obesity (Silver Spring)       Date:  2013-05-13       Impact factor: 5.002

Review 10.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.